Table 1 Baseline characteristics of the study population
From: Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
| Â | No AFLD | Incident AFLD | P value |
|---|---|---|---|
Number | 472 | 168 | Â |
Exerciser, N (%) | 93 (19.7) | 24 (14.3) | 0.12 |
Never smoker, N (%) | 51 (10.8) | 11 (6.5) | 0.18 |
Ex smoker, N (%) | 120 (25.4) | 51 (30.4) | Â |
Current smoker, N (%) | 301 (63.7) | 106 (63.1) | Â |
Diabetes, N (%) | 25 (5.3) | 15 (8.9) | 0.095 |
High blood pressure, N (%) | 191 (40.5) | 91 (54.2) | 0.002 |
High blood glucose, N (%) | 190 (40.3) | 81 (48.2) | 0.073 |
High triglycerides, N (%) | 110 (23.3) | 66 (39.3) | < 0.0001 |
Low HDL-cholesterol, N (%) | 49 (10.4) | 39 (23.2) | < 0.0001 |
Age, year | 48 (14) | 47 (14) | 0.59 |
BMI, kg/m2 | 22 (3.1) | 23.6 (3.8) | < 0.0001 |
Systolic blood pressure, mmHg | 125 (19.5) | 128 (19.9) | 0.002 |
Diastolic blood pressure, mmHg | 80 (14) | 82 (13) | 0.005 |
Fasting blood glucose, mg/dl | 97 (13) | 99 (15) | 0.063 |
HbA1c, % | 5.1 (0.6) | 5.2 (0.8) | 0.2 |
Total cholesterol, mg/dl | 196 (49) | 201 (45.5) | 0.02 |
Triglyserides, mg/dl | 98 (79.8) | 132 (124.7) | < 0.0001 |
HDL-cholesterol, mg/dl | 54.5 (21.5) | 49.2 (20) | < 0.0001 |
LDL-cholesterol, mg/dl | 112 (41.4) | 117.3 (37.8) | 0.019 |
Non HDL-cholesterol, mg/dl | 137.3 (47.5) | 147 (44.5) | < 0.0001 |
AST, IU/L | 21(8) | 22 (9) | 0.87 |
ALT, IU/L | 20 (11.7) | 22 (12) | 0.012 |
GGT, IU/L | 38 (45.5) | 42 (51.5) | 0.078 |
Alb, g/dl | 4.3 (0.3) | 4.3 (0.3) | 0.26 |
Platelet, 104/mL | 23.2 (6.7) | 23.2 (8.1) | 0.93 |
FIB4index | 0.97 (0.54) | 0.89 (0.46) | 0.064 |
NAFLD Fibrosis score | − 2.55 (1.44) | − 2.46 (1.53) | 0.8 |
Alcohol consumption, g/week | 490 (154) | 492 (154) | 0.16 |